Switch to:
More From Other Websites
ChemoCentryx's CCX168, an Orally Administered Complement C5a Receptor Inhibitor, Granted Orphan-Drug... Jun 03 2014
ChemoCentryx receives orphan status for 5a receptor Jun 02 2014
ChemoCentryx's Orally-Administered Complement 5a Receptor Inhibitor, CCX168, Shows Benefit in... Jun 02 2014
CHEMOCENTRYX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
CHEMOCENTRYX, INC. Financials May 20 2014
CHEMOCENTRYX, INC. Files SEC form 10-Q, Quarterly Report May 09 2014
ChemoCentryx's (CCXI) Tom Schall on Q1 2014 Results - Earnings Call Transcript May 08 2014
CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 08 2014
ChemoCentryx reports Q1 EPS (27c), consensus (24c) May 08 2014
ChemoCentryx Announces Financial Results for the First Quarter Ended March 31, 2014 May 08 2014
Q1 2014 ChemoCentryx Inc Earnings Release - After Market Close May 08 2014
Five Small Biotech Stocks Analysts Think Will Triple Apr 30 2014
ChemoCentryx to Hold First Quarter 2014 Financial Results Conference Call on Thursday, May 8, 2014 Apr 29 2014
Why You Shouldn't Bet Against ChemoCentryx (CCXI) Stock Apr 11 2014
ChemoCentryx Appoints Anne-Marie S. Duliege, M.D., M.S. to Chief Strategic Development Role and Head... Mar 27 2014
ChemoCentryx appoints Dr. Anne-Marie Duliege to Chief of Strategic Development Mar 27 2014
ChemoCentryx (CCXI) Shares March Higher, Can It Continue? Mar 20 2014
ChemoCentryx (CCXI) Jumps: Stock Rises 9.8% Mar 19 2014
CHEMOCENTRYX, INC. Files SEC form 10-K, Annual Report Mar 14 2014
ChemoCentryx's CEO Discusses Q4 2013 Results - Earnings Call Transcript Mar 13 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
Email Hide